Orchid gets nod for Granisetron generic formulation

Quotes with Resistance & Support

Market Information

Orchid gets nod for Granisetron generic formulation

This article was posted on Feb 15, 2008 and is filed under Press Releases

Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Granisetron Hydrochloride Tablets. The product is available in 1 mg dosage strength.

An anti-emetic product, Granisetron is a new generation non-antibiotic product.

With limited generic competition, Orchid hopes to garner a strong market share leading to a sizeable revenue contribution from this product.

Sourced From: Orchid Chemicals & Pharmaceuticals Ltd

Tags: calls, daytrading, free calls, intraday, tips

Note: The Credit of this post goes to the original witters of this post and not to NSEGUIDE

Breakouts

+ve » Positive / -ve » Negative

+ve 30 DMA 50 DMA 150 DMA 200 DMA

-ve 30 DMA 50 DMA 150 DMA 200 DMA

Latest Query

Post my query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam

Status: Awaiting reply

Market Stats

Search Our Archives

Research Desk

Stocks Trading above their 50 day moving average - DMA In Stock Research
Download free Ebooks based on Technical Analysis In Personal Training
TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
Charting Pathsala - Your guide to Techincals In Technical Analysis